Easy to integrate with your existing PACS system, NeuroQuant provides automatic brain structure volumetric measurements and compares the volumes to normative reference data adjusted for age, sex, and intracranial volume.
Innovating and Leading the Industry
Reproducible volumetric measurements reduce subjectivity
Automatic post-processing in as little as 5 minutes quickly highlight areas of diagnostic concern from MR, CT, and PET images
Save time with every radiology read through post-processing analysis
Comprehensive objective data in the form of volumetrics and overlay maps improve clinical confidence and support more accurate diagnoses
Objective brain segmentation and volumetrics to aid physicians in the evaluation of neurodegenerative diseases
Segmentation and quantification of FLAIR lesions and brain structures for the evaluation of multiple sclerosis
Automatically label, visualize and obtain the volumetric quantification of segmentable brain structures and lesions from MRI brain studies—within minutes. Accurately visualizing lesions and lesion volume change enables physicians to deliver an efficient, objective assessment of disease activity to determine the best course of treatment more quickly.
Advanced diffusion and automated quantification
OnQ Prostate utilizes artificial intelligence and an advanced diffusion MRI technique called Restriction Spectrum Imaging (RSI) to enable faster, more accurate PI-RADS scoring
Automated tracer activity quantification to aid in the evaluation of dementias
PETQuant utilizes NeuroQuant®‘s automatic brain segmentation to visual and quantify FDG and Florbetapir tracer uptake and provides statistical (Z-score) comparisons of each normalized regional PET tracer value, then compares these values to normative population data.
The Importance of Quantitiative Volumetric Analysis for Brain MRI
Since its introduction, a number of studies have evaluated the use of NeuroQuant automated quantification software in clinical practice, comparing it to other automatic or semi-automatic tools, as well as to manual brain segmentation. Consistently, the studies found that NeuroQuant produced segmentation results that were comparable in accuracy to and more precise than manual segmentations. Additionally, the studies found that NeuroQuant produced results in a faster and more reliable manner than manual segmentation methods.
Current clinical applications range from evaluation of mild cognitive impairment (MCI) to dementia, epilepsy, and multiple sclerosis, as well as traumatic brain injury (TBI) and other neurodegenerative disorders. NeuroQuant’s quantitative volumetric analysis for brain MRI overcomes the initial time-consuming and subjective manual approach obstacles, providing an automated tool suitable for routine clinical use for patients 3 to 100 years of age.
Sophisticated. Accurate. Fully Automated.
Enhance diagnostics & elevate care with advanced datasets, accelerated analyses, and more profound insights.
- CONFIDENTLY ASSESS individual, regional, and global brain structure and lesion volumes
- SAVE TIME with quick identification of brain, enabling a more confident assessment
- IMPROVE PATIENT CARE by quickly identifying the areas of most interest/concern
- REDUCE COSTS with fully automated MRI quantification
Trusted by local imaging centers to world-leading hospitals and universities
“This technology has allowed for improved prostate cancer detection, specifically by helping distinguish aggressive lesions from normal prostate tissue.”Dr. Michael Liss, MDUrology, UT San Antonio
“Adding NeuroQuant to our clinics has led to earlier diagnoses of neurodegenerative diseases with increased diagnostic confidence.”Dr. Pablo Coimbra, MDFortaleza General Hospital Fortaleza
“NeuroQuant allows radiologists to quantify localized brain atrophy in minutes and compare to a large database of normal controls, which was previously not possible in a routine clinical setting.”Dr. Sunil K. Ram, MDNeuroradiologist, Scottsdale Medical Imaging